<code id='AD3A7A8DCB'></code><style id='AD3A7A8DCB'></style>
    • <acronym id='AD3A7A8DCB'></acronym>
      <center id='AD3A7A8DCB'><center id='AD3A7A8DCB'><tfoot id='AD3A7A8DCB'></tfoot></center><abbr id='AD3A7A8DCB'><dir id='AD3A7A8DCB'><tfoot id='AD3A7A8DCB'></tfoot><noframes id='AD3A7A8DCB'>

    • <optgroup id='AD3A7A8DCB'><strike id='AD3A7A8DCB'><sup id='AD3A7A8DCB'></sup></strike><code id='AD3A7A8DCB'></code></optgroup>
        1. <b id='AD3A7A8DCB'><label id='AD3A7A8DCB'><select id='AD3A7A8DCB'><dt id='AD3A7A8DCB'><span id='AD3A7A8DCB'></span></dt></select></label></b><u id='AD3A7A8DCB'></u>
          <i id='AD3A7A8DCB'><strike id='AD3A7A8DCB'><tt id='AD3A7A8DCB'><pre id='AD3A7A8DCB'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:5869
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Trump team launching legal defense fund to help pay legal bills
          Trump team launching legal defense fund to help pay legal bills

          2:42RepublicanpresidentialcandidateformerpresidentDonaldTrumpspeaksattheRepublicanPartyofIowa's2023L

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          How AI helped researchers track recovery from depression

          AdobeResearcherssaythey’vebeenabletomeasurerecoveryfromtreatment-resistantdepressionthroughbrainscan